Theranostics
Combined diagnostic and therapeutic nanoplatforms
Nanobiotix
Paris, France
Clinical-stage biotechnology company pioneering nanomedicine with first-in-class radioenhancers for cancer treatment
Nanospectra Biosciences
Houston, United States
Developer of gold nanoshell-based thermal ablation therapy for cancer treatment
Nanocure
Tel Aviv, Israel
Nanocure, established in 2015 in Tel Aviv, Israel, is an innovative nanomedicine company focused on developing next-generation cancer therapies through advanced nanoparticle-based drug delivery systems. The company's proprietary platform leverages the unique properties of engineered nanoparticles to achieve precise targeting of cancer cells while minimizing damage to healthy tissue, addressing one of the most significant challenges in oncology treatment. Nanocure's targeted nanoparticle therapeutics are designed to overcome the limitations of conventional chemotherapy, which often causes severe side effects due to non-selective distribution throughout the body. The company's nanoparticle formulations utilize sophisticated surface modifications, including targeting ligands and stealth coatings, to enhance circulation time, improve tumor accumulation through the enhanced permeability and retention effect, and facilitate active targeting to specific cancer cell markers. This multifaceted approach enables higher drug concentrations at tumor sites while reducing systemic exposure and associated toxicities. The technology platform is versatile, capable of encapsulating various therapeutic agents including small molecule drugs, peptides, and nucleic acids, making it applicable to multiple cancer types and treatment modalities. Nanocure's nanoparticles are engineered at the nanoscale (typically 10-200 nanometers) to optimize biological interactions, cellular uptake, and intracellular drug release. The company has secured over $15 million in funding to advance its pipeline through preclinical and clinical development stages. Israel's strong biotechnology ecosystem and expertise in nanomedicine provide Nanocure with access to world-class research facilities, clinical networks, and regulatory support. As cancer treatment increasingly moves toward personalized medicine and targeted therapies, Nanocure's nanoparticle platform represents a significant advancement in delivering more effective and safer cancer treatments, positioning the company as an important player in the rapidly evolving field of cancer nanotherapy.
Nanobiotix SA
Cambridge, United States
Clinical-stage nanomedicine company developing first-in-class radioenhancers using hafnium oxide nanoparticles
Nanosphere Biosciences
Boulder, United States
Developer of nanobubble-based therapeutic delivery systems
NanoMedTrix
Berlin, Germany
Nanoparticle-based immunotherapy platform
Exicure
Chicago, United States
Spherical nucleic acid therapeutics platform
Nano Therapeutics
Mumbai, India
Nano-based drug delivery systems for cancer therapy
Nanospectra Biosciences
Houston, United States
Gold nanoshell photothermal ablation therapy for cancer
NH TherAguix
Villeurbanne, France
Gadolinium-based nanoparticles for MRI-guided radiotherapy
Taiwan Liposome Company
Taipei, Taiwan
BioSeizer and NanoX liposomal drug delivery platforms
Celsion Corporation
Lawrenceville, United States
ThermoDox heat-activated liposomal doxorubicin
Oncobiologics
Cranbury, United States
Biosimilar development with advanced formulation technology
Siemens Healthineers
Erlangen, Germany
Medical diagnostics with nanotechnology-based immunoassays and imaging agents
Seagen
Bothell, United States
ADC pioneer (Adcetris, Padcev) acquired by Pfizer
Varian Medical Systems
Palo Alto, United States
Medical device company focused on radiation oncology treatments
Elekta
Stockholm, Sweden
Medical technology company developing precision radiation medicine
nanoTherics
Newcastle upon Tyne, United Kingdom
Magnetic nanoparticle research tools
Nano4Tarmed
Coimbra, Portugal
Nanotechnology platforms for targeted medicine and cancer treatment
Sona Nanotech
Halifax, Canada
Non-toxic gold nanorods for photothermal therapy and tumor-targeting drug delivery
MagForce
Berlin, Germany
Magnetic nanoparticle hyperthermia therapy for brain tumors